Pfizer Acquires Amplyx Pharmaceuticals: What You Need To Know
Pfizer Inc. (NYSE: PFE) has acquired Amplyx Pharmaceuticals Inc., a privately-held company focused on developing therapies for people with compromised immune systems who face debilitating and life-threatening diseases.
